Using a mortalin-specific antibody validated for IHC in our previous reports [12,13], we found that mortalin protein levels were significantly upregulated in PTC, FTC, and ATC but not in the benign tumor tissues (Figure 1A,B). The gene discussed is HSPA9; the disease is neoplasm.